Meiqing Lu

发表

In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

Jason Burch, Yves Ducharme, Louis-Charles Campeau, 2013, Antimicrobial Agents and Chemotherapy.

Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.

D. Gerhold, D. Holder, J. Berger, 2002, Endocrinology.

Androgens drive divergent responses to salt stress in male versus female rat kidneys.

D. Gerhold, B. Connolly, D. Holder, 2007, Genomics.

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp 41 epitope

D. Hazuda, R. Cortese, G. Ciliberto, 2005 .

A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells.

W. Shipe, I. Cornella-Taracido, An Chi, 2022, ACS chemical biology.

Purification of untagged HIV-1 reverse transcriptase by affinity chromatography.

D. Hazuda, M. Lai, Y. Mei, 2010, Protein expression and purification.

Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs).

G. McGaughey, Youwei Yan, L. Gabryelski, 2008, Bioorganic & medicinal chemistry letters.

Assessment of the susceptibility of mutant HIV-1 to antiviral agents.

D. Hazuda, C. Coburn, Kristen L G Jones, 2010, Journal of virological methods.

Monitoring the development of non-nucleoside reverse transcriptase inhibitor-associated resistant HIV-1 using an electrochemiluminescence-based reverse transcriptase polymerase assay.

D. Hazuda, M. Lai, Michael D Miller, 2008, Analytical biochemistry.

Printed in U.S.A. Copyright © 2002 by The Endocrine Society Gene Expression Profile of Adipocyte Differentiation and Its Regulation by Peroxisome Proliferator-Activated

Ansuman Bagchi, Alex Elbrecht, Arthur Fridman, 2022 .

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.

Gennaro Ciliberto, Peter S Kim, Simon Lennard, 2005, Proceedings of the National Academy of Sciences of the United States of America.

A novel rotavirus reverse genetics platform supports flexible insertion of exogenous genes and enables rapid development of a high-throughput neutralization assay

A. Espeseth, Jiajie Wei, M. Citron, 2023, bioRxiv.

Distinct Mutation Pathways of Non-Subtype B HIV-1 during In Vitro Resistance Selection with Nonnucleoside Reverse Transcriptase Inhibitors

D. Hazuda, G. McGaughey, Youwei Yan, 2010, Antimicrobial Agents and Chemotherapy.

Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions

D. Hazuda, M. Lai, V. Munshi, 2016, Viruses.

Antiviral Activity and In Vitro Mutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase Inhibitor

D. Hazuda, G. McGaughey, Youwei Yan, 2012, Antimicrobial Agents and Chemotherapy.

PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver

Margaret S. Wu, D. Gerhold, R. Thieringer, 2000 .

A spectrophotometric method to quantify linear DNA.

C. Satishchandran, Meiqing Lu, C. Pachuk, 2003, Analytical biochemistry.

Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.

Kenneth D Anderson, Youwei Yan, M. Lai, 2009, Bioorganic & Medicinal Chemistry Letters.

Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1

Min Xu, D. Hazuda, M. Bukhtiyarova, 2023, Science Translational Medicine.

Developing and applying ultrasensitive p24 protein immunoassay for HIV latency

D. Hazuda, M. Swanson, D. Graham, 2015 .